Anandamide in primary sensory neurons: Too much of a good thing?

European Journal of Neuroscience

Volumn 39, Issue 3, 2014, Pages 409-418

  Sousa Valente, João ^a   Varga, Angelika ^a   Ananthan, Kajaluxy ^a   Khajuria, Ankur ^a   Nagy, Istvan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesics; Cannabinoid; Dorsal root ganglia; Endogenous cannabinoids; TRPV1

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CAPSAICIN; FATTY ACID AMIDASE; VANILLOID RECEPTOR 1;

ARTICLE; AUTOCRINE EFFECT; ENZYME INHIBITION; EXCITATION; HUMAN; INTRACELLULAR SIGNALING; LIPID HYDROLYSIS; LIPID TRANSPORT; NERVE CELL INHIBITION; NOCICEPTION; NONHUMAN; PRIMARY SENSORY NEURON; PRIORITY JOURNAL; SENSORY NERVE CELL;

ANALGESICS; CANNABINOID; DORSAL ROOT GANGLIA; ENDOGENOUS CANNABINOIDS; TRPV1;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR AGONISTS; ENDOCANNABINOIDS; HUMANS; NOCICEPTORS; PAIN; POLYUNSATURATED ALKAMIDES; TRPV CATION CHANNELS;

EID: 84893425359     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12467     Document Type: Article

References (160)

1. Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C.E., Brenner, G.J., Rubino, T., Michalski, C.W., Marsicano, G., Monory, K., Mackie, K., Marian, C., Batkai, S., Parolaro, D., Fischer, M.J., Reeh, P., Kunos, G., Kress, M., Lutz, B., Woolf, C.J. & Kuner, R. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci., 10, 870-879.
2. Ahern, G.P. (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J. Biol. Chem., 278, 30429-30434.
3. Ahluwalia, J., Urban, L., Capogna, M., Bevan, S. & Nagy, I. (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685-688.
4. Ahluwalia, J., Urbán, L., Bevan, S. & Nagy, I. (2003) Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci., 17, 2611-2618.
5. Amaya, F., Shimosato, G., Kawasaki, Y., Hashimoto, S., Tanaka, Y., Ji, R.-R. & Tanaka, M. (2006) Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist. Pain, 124, 175-183.
6. Barrière, D.A., Mallet, C., Blomgren, A., Simonsen, C., Daulhac, L., Libert, F., Chapuy, E., Etienne, M., Högestätt, E.D., Zygmunt, P.M. & Eschalier, A. (2013) Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. PLoS ONE, 8, e70690.
7. Basbaum, A.I., Bautista, D.M., Scherrer, G. & Julius, D. (2009) Cellular and molecular mechanisms of pain. Cell, 139, 267-284.
8. Bhave, G., Zhu, W., Wang, H., Brasier, D.J., Oxford, G.S. & Gereau, R.W. (2002) cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron, 35, 721-731.
9. Bhave, G., Hu, H.-J., Glauner, K.S., Zhu, W., Wang, H., Brasier, D.J., Oxford, G.S. & Gereau, R.W. (2003) Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. USA, 100, 12480-12485.
10. Binzen, U., Greffrath, W., Hennessy, S., Bausen, M., Saaler-Reinhardt, S. & Treede, R.D. (2006) Co-expression of the voltage-gated potassium channel Kv1.4 with transient receptor potential channels (TRPV1 and TRPV2) and the cannabinoid receptor CB1 in rat dorsal root ganglion neurons. Neuroscience, 142, 527-539.
11. Birder, L.A., Kanai, A.J., de Groat, W.C., Kiss, S., Nealen, M.L., Burke, N.E., Dineley, K.E., Watkins, S., Reynolds, I.J. & Caterina, M.J. (2001) Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc. Natl. Acad. Sci. USA, 98, 13396-13401.
12. Bouaboula, M., Poinot-Chazel, C., Bourrié, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G. & Casellas, P. (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J., 312, 637-641.
13. Bridges, D., Rice, A.S.C., Egertová, M., Elphick, M.R., Winter, J. & Michael, G.J. (2003) Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience, 119, 803-812.
14. Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature, 394, 277-281.
15. Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D. & Julius, D. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389, 816-824.
16. Caterina, M.J., Leffler, A., Malmberg, A.B., Martin, W.J., Trafton, J., Petersen-Zeitz, K.R., Koltzenburg, M., Basbaum, A.I. & Julius, D. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 306-313.
17. Chang, L., Luo, L., Palmer, J.A., Sutton, S., Wilson, S.J., Barbier, A.J., Breitenbucher, J.G., Chaplan, S.R. & Webb, M. (2006) Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Brit. J. Pharmacol., 148, 102-113.
18. Charrua, A., Cruz, C.D., Cruz, F. & Avelino, A. (2007) Transient Receptor Potential Vanilloid Subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J. Urology, 177, 1537-1541.
19. Chen, J.J., Vasko, M.R., Wu, X., Staeva, T.P., Baez, M., Zgombick, J.M. & Nelson, D.L. (1998) Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J. Pharmacol. Exp. Ther., 287, 1119-1127.
20. Chen, J., Mlynarczyk, M. & Nagy, I. (2010) Anandamide-induced currents in rat cultured primary sensory neurons. Proc. Physiol. Soc., 20, 29.
21. Christensen, R., Kristensen, P.K., Bartels, E.M., Bliddal, H. & Astrup, A. (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet, 370, 1706-1713.
22. Clapper, J.R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N.R., Spradley, J.M., Hohmann, A.G., Calignano, A., Mor, M., Tarzia, G. & Piomelli, D. (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat. Neurosci., 13, 1265-1270.
23. Costa, B., Bettoni, I., Petrosino, S., Comelli, F., Giagnoni, G. & Di Marzo, V. (2010) The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. Pharmacol. Res., 61, 537-546.
24. Craib, S.J., Ellington, H.C., Pertwee, R.G. & Ross, R.A. (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Brit. J. Pharmacol., 134, 30-37.
25. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A. & Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
26. Davis, J.B., Gray, J., Gunthorpe, M.J., Hatcher, J.P., Davey, P.T., Overend, P., Harries, M.H., Latcham, J., Clapham, C. & Atkinson, K. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 405, 183-187.
27. De Petrocellis, L., Harrison, S., Bisogno, T., Tognetto, M., Brandi, I., Smith, G.D., Creminon, C., Davis, J.B., Geppetti, P. & Di Marzo, V. (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem., 77, 1660-1663.
28. Deadwyler, S.A., Hampson, R.E., Mu, J., Whyte, A. & Childers, S. (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther., 273, 734-743.
29. Delany, N.S., Hurle, M., Facer, P., Alnadaf, T., Plumpton, C., Kinghorn, I., See, C.G., Costigan, M., Anand, P., Woolf, C.J., Crowther, D., Sanseau, P. & Tate, S.N. (2001) Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2. Physiol. Genomics, 4, 165-174.
30. Derkinderen, P., Ledent, C., Parmentier, M. & Girault, J.A. (2001) Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J. Neurochem., 77, 957-960.
31. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
32. Di Marzo, V. & Petrocellis, L. (2010) Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs. Curr. Med. Chem., 17, 1430-1449.
33. Di Marzo, V. & Petrosino, S. (2007) Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol., 18, 129-140.
34. Di Marzo, V., De Petrocellis, L., Sepe, N. & Buono, A. (1996) Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem. J., 316, 977-984.
35. Di Marzo, V., Melck, D., Bisogno, T. & De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci., 21, 521-528.
36. Dinis, P., Charrua, A., Avelino, A. & Cruz, F. (2004a) Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU Int., 94, 153-157.
37. Dinis, P., Charrua, A., Avelino, A., Yaqoob, M., Bevan, S., Nagy, I. & Cruz, F. (2004b) Anandamide-evoked activation of Vanilloid Receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J. Neurosci., 24, 11253-11263.
38. Engel, M.A., Izydorczyk, I., Mueller-Tribbensee, S.M., Becker, C., Neurath, M.F. & Reeh, P.W. (2011) Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin. Neuropeptides, 45, 229-237.
39. Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G. & Piomelli, D. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther., 313, 352-358.
40. Fioravanti, B., De Felice, M., Stucky, C.L., Medler, K.A., Luo, M.-C., Gardell, L.R., Ibrahim, M., Malan, T.P., Yamamura, H.I., Ossipov, M.H., King, T., Lai, J., Porreca, F. & Vanderah, T.W. (2008) Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J. Neurosci., 28, 11593-11602.
41. Fischbach, T., Greffrath, W., Nawrath, H. & Treede, R.-D. (2007) Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats. J. Neurophysiol., 98, 929-938.
42. Fu, J., Gaetani, S., Oveisi, F., Verme, J.L., Serrano, A., de Fonseca, F.R., Rosengarth, A., Luecke, H., Di Giacomo, B. & Tarzia, G. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature, 425, 90-93.
43. Fu, J., Bottegoni, G., Sasso, O., Bertorelli, R., Rocchia, W., Masetti, M., Guijarro, A., Lodola, A., Armirotti, A., Garau, G., Bandiera, T., Reggiani, A., Mor, M., Cavalli, A. & Piomelli, D. (2012) A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat. Neurosci., 15, 64-69.
44. Fucile, S., Sucapane, A. & Eusebi, F. (2005) Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones. J. Physiol., 565, 219-228.
45. Garcia, D.E., Brown, S., Hille, B. & Mackie, K. (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J. Neurosci., 18, 2834-2841.
46. Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A., Maione, S. & Di Marzo, V. (2012) Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS ONE, 7, e31111.
47. Ghafouri, N., Ghafouri, B., Larsson, B., Stensson, N., Fowler, C.J. & Gerdle, B. (2013) Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity. Pain, 154, 1649-1658.
48. Giang, D.K. & Cravatt, B.F. (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA, 94, 2238-2242.
49. Giordano, C., Cristino, L., Luongo, L., Siniscalco, D., Petrosino, S., Piscitelli, F., Marabese, I., Gatta, L., Rossi, F., Imperatore, R., Palazzo, E., de Novellis, V., Di Marzo, V. & Maione, S. (2012) TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception. Cereb. Cortex, 22, 2495-2518.
50. Glass, M. & Felder, C.C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci., 17, 5327-5333.
51. Goodfellow, C.E. & Glass, M. (2009) Anandamide receptor signal transduction. Vitam. Horm., 81, 79-110.
52. Guo, A., Vulchanova, L., Wang, J., Li, X. & Elde, R. (1999) Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci., 11, 946-958.
53. Guo, Y., Wang, H., Okamoto, Y., Ueda, N., Kingsley, P.J., Marnett, L.J., Schmid, H.H.O., Das, S.K. & Dey, S.K. (2005) N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem., 280, 23429-23432.
54. Haberberger, R.V., Bernardini, N., Kress, M., Hartmann, P., Lips, K.S. & Kummer, W. (2004) Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. Auton. Neurosci., 113, 32-42.
55. Hampson, A.J., Bornheim, L.M., Scanziani, M., Yost, C.S., Gray, A.T., Hansen, B.M., Leonoudakis, D.J. & Bickler, P.E. (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem., 70, 671-676.
56. Hehn von, C.A., Baron, R. & Woolf, C.J. (2012) Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron, 73, 638-652.
57. Helyes, Z., Németh, J., Thán, M., Bölcskei, K., Pintér, E. & Szolcsányi, J. (2003) Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat. Life Sci., 73, 2345-2353.
58. Hermann, H., De Petrocellis, L., Bisogno, T., Moriello, A.S., Lutz, B. & Di Marzo, V. (2003) Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell. Mol. Life Sci., 60, 607-616.
59. Hohmann, A.G. & Herkenham, M. (1999) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience, 90, 923-931.
60. Huang, C.-C., Chen, Y.-L., Lo, S.-W. & Hsu, K.-S. (2002) Activation of cAMP-dependent protein kinase suppresses the presynaptic cannabinoid inhibition of glutamatergic transmission at corticostriatal synapses. Mol. Pharmacol., 61, 578-585.
61. Huggins, J.P., Smart, T.S., Langman, S., Taylor, L. & Young, T. (2012) An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain, 153, 1837-1846.
62. Jarrahian, A. & Hillard, C.J. (1997) Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes. Prostag. Leukotr. Ess., 57, 551-554.
63. Jhaveri, M.D., Richardson, D., Kendall, D.A., Barrett, D.A. & Chapman, V. (2006) Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci., 26, 13318-13327.
64. Jhaveri, M.D., Richardson, D., Robinson, I., Garle, M.J., Patel, A., Sun, Y., Sagar, D.R., Bennett, A.J., Alexander, S.P.H., Kendall, D.A., Barrett, D.A. & Chapman, V. (2008) Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology, 55, 85-93.
65. Johnson, D.E., Heald, S.L., Dally, R.D. & Janis, R.A. (1993) Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1, 4-dihydropyridine binding. Prostag. Leukotr. Ess., 48, 429-437.
66. Kagaya, M., Lamb, J., Robbins, J., Page, C.P. & Spina, D. (2002) Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Brit. J. Pharmacol., 137, 39-48.
67. Kanai, Y., Nakazato, E., Fujiuchi, A., Hara, T. & Imai, A. (2005) Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology, 49, 977-984.
68. Kelly, S., Jhaveri, M.D., Sagar, D.R., Kendall, D.A. & Chapman, V. (2003) Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. Eur. J. Neurosci., 18, 2239-2243.
69. Khasabova, I.A., Harding-Rose, C., Simone, D.A. & Seybold, V.S. (2004) Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J. Neurosci., 24, 1744-1753.
70. Khasabova, I.A., Khasabov, S.G., Harding-Rose, C., Coicou, L.G., Seybold, B.A., Lindberg, A.E., Steevens, C.D., Simone, D.A. & Seybold, V.S. (2008) A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. J. Neurosci., 28, 11141-11152.
71. Khasabova, I.A., Khasabov, S., Paz, J., Harding-Rose, C., Simone, D.A. & Seybold, V.S. (2012) Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. J. Neurosci., 32, 7091-7101.
72. Khasabova, I.A., Holman, M., Morse, T., Burlakova, N., Coicou, L., Harding-Rose, C., Simone, D.A. & Seybold, V.S. (2013) Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain. Neurobiol. Dis., 58, 19-28.
73. Kim, Y.H., Back, S.K., Davies, A.J., Jeong, H., Jo, H.J., Chung, G., Na, H.S., Bae, Y.C., Kim, S.J., Kim, J.S., Jung, S.J. & Oh, S.B. (2012) TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron, 74, 640-647.
74. Kimura, T., Ohta, T., Watanabe, K., Yoshimura, H. & Yamamoto, I. (1998) Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. Biol. Pharm. Bull., 21, 224-226.
75. Köles, L., Garção, P., Zádori, Z.S., Ferreira, S.G., Pinheiro, B.S., da Silva-Santos, C.S., Ledent, C. & Köfalvi, A. (2013) Presynaptic TRPV1 vanilloid receptor function is age- but not CB1 cannabinoid receptor-dependent in the rodent forebrain. Brain Res. Bull., 97, 126-135.
76. Kollarik, M. & Undem, B.J. (2004) Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice. J. Physiol., 555, 115-123.
77. Koplas, P.A., Rosenberg, R.L. & Oxford, G.S. (1997) The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons. J. Neurosci., 17, 3525-3537.
78. Lagalwar, S., Bordayo, E.Z., Hoffmann, K.L., Fawcett, J.R. & Frey, W.H. II (1999) Anandamides inhibit binding to the muscarinic acetylcholine receptor. J. Mol. Neurosci., 13, 55-61.
79. Lauckner, J.E., Hille, B. & Mackie, K. (2005) The cannabinoid agonist WIN55, 212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. USA, 102, 19144-19149.
80. Lauckner, J.E., Jensen, J.B., Chen, H.-Y., Lu, H.-C., Hille, B. & Mackie, K. (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc. Natl. Acad. Sci. USA, 105, 2699-2704.
81. Lever, I.J., Robinson, M., Cibelli, M., Paule, C., Sántha, P., Yee, L., Hunt, S.P., Cravatt, B.F., Elphick, M.R., Nagy, I. & Rice, A.S.C. (2009) Localization of the endocannabinoid-degrading enzyme fatty acid amide hydrolase in rat dorsal root ganglion cells and its regulation after peripheral nerve injury. J. Neurosci., 29, 3766-3780.
82. Li, J., McRoberts, J.A., Nie, J., Ennes, H.S. & Mayer, E.A. (2004) Electrophysiological characterization of N-methyl-D-aspartate receptors in rat dorsal root ganglia neurons. Pain, 109, 443-452.
83. Liu, Y.-Q., Qiu, F., Qiu, C.-Y., Cai, Q., Zou, P., Wu, H. & Hu, W.-P. (2012) Cannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons. PLoS ONE, 7, e45531.
84. Lizanecz, E., Bagi, Z., Pásztor, E.T., Papp, Z., Édes, I., Kedei, N., Blumberg, P.M. & Tóth, A. (2006) Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. Mol. Pharmacol., 69, 1015-1023.
85. Mackie, K. & Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA, 89, 3825-3829.
86. Mackie, K., Lai, Y., Westenbroek, R. & Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci., 15, 6552-6561.
87. Mahmud, A., Santha, P., Paule, C.C. & Nagy, I. (2009) Cannabinoid 1 receptor activation inhibits Transient Receptor Potential Vanilloid Type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. Neuroscience, 162, 1202-1211.
88. Maingret, F., Patel, A.J., Lazdunski, M. & Honoré, E. (2001) The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J., 20, 47-54.
89. Maione, S., Costa, B., Piscitelli, F., Morera, E., De Chiaro, M., Comelli, F., Boccella, S., Guida, F., Verde, R., Ortar, G. & Di Marzo, V. (2013) Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. Pharmacol. Res., 76, 98-105.
90. Maneuf, Y.P. & Brotchie, J.M. (1997) Paradoxical action of the cannabinoid WIN 55, 212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Brit. J. Pharmacol., 120, 1397-1398.
91. Matias, I., Chen, J., De Petrocellis, L., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A.H.-P., Shi, L., Protzman, C.E., Li, C., Liang, Y., Nieves, A.L., Kedzie, K.M., Burk, R.M., Di Marzo, V. & Woodward, D.F. (2004) Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther., 309, 745-757.
92. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
93. Mazzola, C., Medalie, J., Scherma, M., Panlilio, L.V., Solinas, M., Tanda, G., Drago, F., Cadet, J.L., Goldberg, S.R. & Yasar, S. (2009) Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn. Memory, 16, 332-337.
94. McGaraughty, S., Chu, K.L., Bitner, R.S., Martino, B., El Kouhen, R., Han, P., Nikkel, A.L., Burgard, E.C., Faltynek, C.R. & Jarvis, M.F. (2003) Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM. J. Neurophysiol., 90, 2702-2710.
95. McVey, D.C., Schmid, P.C., Schmid, H.H. & Vigna, S.R. (2003) Endocannabinoids induce ileitis in rats via the Capsaicin Receptor (VR1). J. Pharmacol. Exp. Ther., 304, 713-722.
96. Michael, G.J. & Priestley, J.V. (1999) Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci., 19, 1844-1854.
97. Millns, P.J., Chimenti, M., Ali, N., Ryland, E., de Lago, E., Fernandez-Ruiz, J., Chapman, V. & Kendall, D.A. (2006) Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB1 receptors. Eur. J. Neurosci., 24, 3489-3495.
98. Mitrirattanakul, S., Ramakul, N., Guerrero, A.V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K.F. & Spigelman, I. (2006) Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain, 126, 102-114.
99. Mlynarczyk, M. & Nagy, I. (2010) Characterisation of n-arachidonoylethanolamine (Anandamide)-induced transient receptor potential vanilloid type 1 ion channel (TRPV1)-mediated responses in rat cultured primary sensory neurons (PSN). Acta Physiol. Hung., 97, 461.
100. Molina-Holgado, E., Vela, J.M., Arévalo-Martín, A., Almazán, G., Molina-Holgado, F., Borrell, J. & Guaza, C. (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J. Neurosci., 22, 9742-9753.
101. Moreira, F.A. & Crippa, J.A.S. (2009) The psychiatric side-effects of rimonabant. Rev. Bras. Psiquiatr., 31, 145-153.
102. Morisset, V. & Urbán, L. (2001) Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. J. Neurophysiol., 86, 40-48.
103. Morisset, V., Ahluwalia, J., Nagy, I. & Urban, L. (2001) Possible mechanisms of cannabinoid-induced antinociception in the spinal cord. Eur. J. Pharmacol., 429, 93-100.
104. Nagy, I. (2004) Sensory processing: Primary afferent neurons/DRG. In Evers, A.S. & Maze, M. (Eds), Anesthetic Pharmacology: Physiologic Principles and Clinical Practice. Churchill Livingstone, Philadelphia, pp. 187-197.
105. Nagy, I., Sántha, P., Jancsó, G. & Urbán, L. (2004) The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol., 500, 351-369.
106. Nagy, B., Fedonidis, C., Photiou, A., Wahba, J., Paule, C.C., Ma, D., Buluwela, L. & Nagy, I. (2009) Capsaicin-sensitive primary sensory neurons in the mouse express N-Acyl phosphatidylethanolamine phospholipase D. Neuroscience, 161, 572-577.
107. Németh, J., Helyes, Z., Thán, M., Jakab, B., Pintér, E. & Szolcsányi, J. (2003) Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae. Neurosci. Lett., 336, 89-92.
108. Numazaki, M., Tominaga, T., Toyooka, H. & Tominaga, M. (2002) Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J. Biol. Chem., 277, 13375-13378.
109. Okine, B.N., Norris, L.M., Woodhams, S., Burston, J., Patel, A., Alexander, S.P., Barrett, D.A., Kendall, D.A., Bennett, A.J. & Chapman, V. (2012) Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. Brit. J. Pharmacol., 167, 627-640.
110. Opitz, C.A., Rimmerman, N., Zhang, Y., Mead, L.E., Yoder, M.C., Ingram, D.A., Walker, J.M. & Rehman, J. (2007) Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. FEBS Lett., 581, 4927-4931.
111. Oz, M., Ravindran, A., Diaz-Ruiz, O., Zhang, L. & Morales, M. (2003) The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J. Pharmacol. Exp. Ther., 306, 1003-1010.
112. Palazzo, E., Luongo, L., de Novellis, V., Rossi, F., Marabese, I. & Maione, S. (2012) Transient Receptor Potential Vanilloid type 1 and pain development. Curr. Opin. Pharmacol., 12, 9-17.
113. Paria, B.C., Deutsch, D.D. & Dey, S.K. (1996) The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol. Reprod. Dev., 45, 183-192.
114. Patapoutian, A., Peier, A.M., Story, G.M. & Viswanath, V. (2003) Sensory systems: thermotrp channels and beyond: mechanisms of temperature sensation. Nat. Rev. Neurosci., 4, 529-539.
115. Pertwee, R.G. (2005) The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J., 7, 625-654.
116. Petrosino, S., Ligresti, A. & Di Marzo, V. (2009) Endocannabinoid chemical biology: a tool for the development of novel therapies. Curr. Opin. Chem. Biol., 13, 309-320.
117. Piscitelli, F. & Di Marzo, V. (2012) "Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control. ACS Chem. Neurosci., 3, 356-363.
118. + channels. Neuropharmacology, 35, 983-991.
119. Pollema-Mays, S.L., Centeno, M.V., Ashford, C.J., Apkarian, A.V. & Martina, M. (2013) Expression of background potassium channels in rat DRG is cell-specific and down-regulated in a neuropathic pain model. Mol. Cell. Neurosci., 57, 1-9.
120. Potenzieri, C., Brink, T.S. & Simone, D.A. (2009) Excitation of cutaneous C nociceptors by intraplantar administration of anandamide. Brain Res., 1268, 38-47.
121. Premkumar, L.S. & Ahern, G.P. (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature, 408, 985-990.
122. Re, G., Barbero, R., Miolo, A. & Di Marzo, V. (2007) Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. Vet. J., 173, 21-30.
123. Rhee, M.H., Bayewitch, M., Avidor-Reiss, T., Levy, R. & Vogel, Z. (1998) Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J. Neurochem., 71, 1525-1534.
124. Richardson, J.D., Kilo, S. & Hargreaves, K.M. (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB 1 receptors. Pain, 75, 111-119.
125. Roques, B.P., Fournié-Zaluski, M.-C. & Wurm, M. (2012) Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat. Rev. Drug Discov., 11, 292-310.
126. Rowbotham, M.C., Nothaft, W., Duan, W.R., Wang, Y., Faltynek, C., McGaraughty, S., Chu, K.L. & Svensson, P. (2011) Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. Pain, 152, 1192-1200.
127. Russo, R., Loverme, J., La Rana, G., Compton, T.R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A. & Piomelli, D. (2007) The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J. Pharmacol. Exp. Ther., 322, 236-242.
128. Sagar, D.R., Jhaveri, M.D., Richardson, D., Gray, R.A., de Lago, E., Fernández-Ruiz, J., Barrett, D.A., Kendall, D.A. & Chapman, V. (2010) Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Eur. J. Neurosci., 31, 1414-1422.
129. Santha, P., Jenes, Á., Somogyi, C. & Nagy, I. (2010) The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons. Acta Physiol. Hung., 97, 149-158.
130. Sasso, O., Bertorelli, R., Bandiera, T., Scarpelli, R., Colombano, G., Armirotti, A., Moreno-Sanz, G., Reggiani, A. & Piomelli, D. (2012) Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions. Pharmacol. Res., 65, 553-563.
131. Sato, K., Kyama, H., Park, H.T. & Tohyama, M. (1993) AMPA, KA and NMDA receptors are expressed in the rat DRG neurones. NeuroReport, 4, 1263-1265.
132. Scholz, J. & Woolf, C.J. (2002) Can we conquer pain? Nat. Neurosci., 5, 1062-1067.
133. Selvarajah, S., Chen, J., Varga, A., Brain, S., White, J., Urban, L., Buluwela, L. & Nagy, I. (2012) The role of cannabinoid 1 Receptor (CB1) In N-arachidonylethanolamine (anandamide) responsiveness of the Transient Receptor Potential Vanilloid type 1 ion channel (TRPV1) in cultured rat primary sensory neurons (PSN). Available http://www.pa2online.org/abstract/abstract.jsp?abid=30880&author=Nagy&cat=-1&period=52.
134. Shimasue, K., Urushidani, T., Hagiwara, M. & Nagao, T. (1996) Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2 + channel. Eur. J. Pharmacol., 296, 347-350.
135. Singh Tahim, A., Santha, P. & Nagy, I. (2005) Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. Neuroscience, 136, 539-548.
136. Soneji, N.D., Paule, C.C., Mlynarczyk, M. & Nagy, I. (2010) Effects of cannabinoids on capsaicin receptor activity following exposure of primary sensory neurons to inflammatory mediators. Life Sci., 87, 162-168.
137. Starowicz, K., Makuch, W., Osikowicz, M., Piscitelli, F., Petrosino, S., Di Marzo, V. & Przewlocka, B. (2012) Spinal anandamide produces analgesia in neuropathic rats: possible CB1- and TRPV1-mediated mechanisms. Neuropharmacology, 62, 1746-1755.
138. Starowicz, K., Makuch, W., Korostynski, M., Malek, N., Slezak, M., Zychowska, M., Petrosino, S., De Petrocellis, L., Cristino, L., Przewlocka, B. & Di Marzo, V. (2013) Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. PLoS ONE, 8, e60040.
139. van der Stelt, M., Trevisani, M., Vellani, V., De Petrocellis, L., Moriello, A.S., Campi, B., McNaughton, P., Geppetti, P. & Di Marzo, V. (2005) Anandamide acts as an intracellular messenger amplifying Ca2 + ; influx via TRPV1 channels. EMBO J., 24, 3026-3037.
140. Sun, Y., Alexander, S., Garle, M.J., Gibson, C.L., Hewitt, K., Murphy, S.P., Kendall, D.A. & Bennett, A.J. (2007) Cannabinoid activation of PPARα; a novel neuroprotective mechanism. Brit. J. Pharmacol., 152, 734.
141. Tognetto, M., Amadesi, S., Harrison, S., Creminon, C., Trevisani, M., Carreras, M., Matera, M., Geppetti, P. & Bianchi, A. (2001) Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J. Neurosci., 21, 1104-1109.
142. Tominaga, M., Caterina, M.J., Malmberg, A.B., Rosen, T.A., Gilbert, H., Skinner, K., Raumann, B.E., Basbaum, A.I. & Julius, D. (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 21, 531-543.
143. Tóth, A., Wang, Y., Kedei, N., Tran, R., Pearce, L.V., Kang, S.-U., Jin, M.-K., Choi, H.-K., Lee, J. & Blumberg, P.M. (2005) Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. Life Sci., 76, 2921-2932.
144. Traynor, K. (2007) Panel advises against rimonabant approval. Am. J. Health Syst. Pharm., 64, 1460-1461.
145. Twitchell, W., Brown, S. & Mackie, K. (1997) Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol., 78, 43-50.
146. Valente, J., Tailor, H., Jenes, A., Mackie, K., Cravatt, B.F., Buluwala, L., Avelino, A. & Nagy, I. (2011) Expression of N-acyl phosphotidylethanolamine phospholipase D in rat dorsal root ganglion neurons. Proc. Physiol. Soc., 22, PC25.
147. Valjent, E., Rogard, M., Besson, M.J., Maldonado, R. & Caboche, J. (2001) Δ9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci., 14, 342-352.
148. Varga, A., Jenes, A., Buluwela, L. & Nagy, I. (2011) Expression of N-arachidonoylethanolamine (anandamide)-synthetizing enzymes in rat primary sensory neurons. Proc. Physiol. Soc., 22, PC09.
149. 2+ -insensitive enzymes induces excitation in primary sensory neurons. Pflug. Arch., DOI: 10.1007/s00424-013-1360-7. [Epub ahead of print].
150. Vellani, V., Mapplebeck, S., Moriondo, A., Davis, J.B. & McNaughton, P.A. (2001) Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol., 534, 813-825.
151. Veress, G., Meszar, Z., Muszil, D., Avelino, A., Matesz, K., Mackie, K. & Nagy, I. (2013) Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons. Brain Struct. Funct., 218, 733-750.
152. Verme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., Calignano, A. & Piomelli, D. (2005) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol., 67, 15-19.
153. Walker, K.M., Urbán, L., Medhurst, S.J., Patel, S., Panesar, M., Fox, A.J. & McIntyre, P. (2003) The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther., 304, 56-62.
154. Watanabe, H., Vriens, J., Prenen, J., Droogmans, G., Voets, T. & Nilius, B. (2003) Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature, 424, 434-438.
155. Weller, K., Reeh, P.W. & Sauer, S.K. (2011) TRPV1, TRPA1, and CB1 in the isolated vagus nerve - Axonal chemosensitivity and control of neuropeptide release. Neuropeptides, 45, 391-400.
156. White, J.P.M., Urbán, L. & Nagy, I. (2011) TRPV1 function in health and disease. Curr. Pharm. Biotechno., 12, 130-144.
157. Woolf, C.J. (2010) Overcoming obstacles to developingnew analgesics. Nat. Med., 16, 1241-1247.
158. Woolf, C.J. & Ma, Q. (2007) Nociceptors-noxious stimulus detectors. Neuron, 55, 353-364.
159. Yang, Y., Yang, H., Wang, Z., Varadaraj, K., Kumari, S.S., Mergler, S., Okada, Y., Saika, S., Kingsley, P.J., Marnett, L.J. & Reinach, P.S. (2013) Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury. Cell. Signal., 25, 501-511.
160. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D. & Högestätt, E.D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.